scispace - formally typeset
I

Irving F. Hoffman

Researcher at University of North Carolina at Chapel Hill

Publications -  288
Citations -  20382

Irving F. Hoffman is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 52, co-authored 270 publications receiving 18634 citations. Previous affiliations of Irving F. Hoffman include Kamuzu Central Hospital & FHI 360.

Papers
More filters
Journal ArticleDOI

Policy to practice: impact of GeneXpert MTB/RIF implementation on the TB spectrum of care in Lilongwe, Malawi

TL;DR: GeneXpert contributed minimally to overall TB diagnosis and the cascade of care due to implementation challenges of sputum collection, empiric treatment, and weak linkage to care between inpatient and outpatient settings.
Journal ArticleDOI

Effects of community-level bed net coverage on malaria morbidity in Lilongwe, Malawi

TL;DR: Investigating the effect of community-level bed net use against malaria transmission outside of a bed net clinical trial setting in Lilongwe, Malawi found efforts to scale-up ownership of long-lasting, insecticide-treated bed nets are effective in increasing reported use.
Journal ArticleDOI

Adherence to extended postpartum antiretrovirals is associated with decreased breast milk HIV-1 transmission

Nicole L. Davis, +127 more
- 28 Nov 2014 - 
TL;DR: Nonadherence to extended postpartum antiretroviral regimens in ‘real world’ settings is likely to be higher than that seen in BAN, and identifying mothers with difficulty adhering to antireTrovirals, and developing effective adherence interventions, will help maximize benefits of antire troviral provision throughout breastfeeding.
Journal ArticleDOI

A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.

TL;DR: A pilot clinical trial in which HIV-infected and uninfected women were randomized to either depot medroxyprogesterone acetate (DMPA) injectable or levonorgestrel (LNG) implant in Lilongwe, Malawi to assess the effect and compare the impact of type of progestin contraception (injectable versus implant) on HIV genital shedding among HIV- infected women.